{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:40:44Z","timestamp":1793677244221,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2025.12.994","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T23:39:59Z","timestamp":1767224399000},"page":"466.e1-466.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in the Central Nervous System"],"prefix":"10.1016","volume":"32","author":[{"given":"Alexander","family":"Denk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-3190","authenticated-orcid":false,"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5662-2630","authenticated-orcid":false,"given":"Matthias A.","family":"Fante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Schweiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-2187","authenticated-orcid":false,"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-8829","authenticated-orcid":false,"given":"Klemens","family":"Angstwurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2025.12.994_bib0001","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/brain\/awae340","article-title":"CNS manifestations in acute and chronic graft-versus-host disease","volume":"148","author":"Lambert","year":"2025","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.jtct.2025.12.994_bib0002","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.994_bib0003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbmt.2015.10.018","article-title":"Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"22","author":"Arora","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2025.12.994_bib0004","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.994_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.12.994_bib0006","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","first-page":"331","article-title":"Chronic graft-versus-host disease","author":"Wolff","year":"2019"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.994_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a Task Force Report from the National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"10.1016\/j.jtct.2025.12.994_bib0008","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.994_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-host Disease: I. Diagnosis and Staging Working Group Report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.994_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.994_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical trials in chronic graft-versus-host disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.994_bib0012","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 Highly Morbid Forms Report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.994_bib0013","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jtct.2022.05.038","article-title":"Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 National Institutes of Health Consensus Project Task Force","volume":"28","author":"Cuvelier","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.994_bib0014","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2012-09-456590","article-title":"The central nervous system is a target of acute graft versus host disease in mice","volume":"121","author":"Hartrampf","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.994_bib0015","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2014-01-547612","article-title":"CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis","volume":"123","author":"Kaliyaperumal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.994_bib0016","article-title":"A case report of central nervous system graft-versus-host disease and literature review","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"issue":"42","key":"10.1016\/j.jtct.2025.12.994_bib0017","doi-asserted-by":"crossref","first-page":"e8303","DOI":"10.1097\/MD.0000000000008303","article-title":"Case report: central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature","volume":"96","author":"Ruggiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.994_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/bloodadvances.2017011478","article-title":"Successful treatment with fingolimod of graft-versus-host disease of the central nervous system","volume":"2","author":"Gauthier","year":"2018","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.994_bib0019","doi-asserted-by":"crossref","first-page":"772.e1","DOI":"10.1016\/j.jtct.2023.09.016","article-title":"Incidence and outcome of atypical manifestations of chronic graft-versus-host disease: results from a retrospective single-center analysis","volume":"29","author":"Doering","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.994_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000439490","article-title":"Retinal involvement in a patient with cerebral manifestation of chronic graft-versus-host-disease","volume":"38","author":"Blecha","year":"2015","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.994_bib0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.994_bib0022","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.994_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.994_bib0024","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.bbmt.2019.05.024","article-title":"Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Balaguer-Rosello","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.994_bib0025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","article-title":"Prospective evaluation of neurological complications after allogeneic bone marrow transplantation","volume":"60","author":"Sostak","year":"2003","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.994_bib0026","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.994_bib0027","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood.2021011671","article-title":"Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice","volume":"139","author":"Adams","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.994_bib0028","series-title":"Chronic Graft Versus Host Disease: Interdisciplinary Management","first-page":"243","article-title":"Neurological manifestations of chronic graft versus host disease","author":"Openshaw","year":"2009"},{"issue":"15","key":"10.1016\/j.jtct.2025.12.994_bib0029","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jtct.2025.12.994_bib0030","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","article-title":"Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years","volume":"29","author":"Syrjala","year":"2011","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.jtct.2025.12.994_bib0031","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/bloodadvances.2021004941","article-title":"Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium","volume":"5","author":"DeFilipp","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.994_bib0032","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.994_bib0033","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI130272","article-title":"Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia","volume":"130","author":"Mathew","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:33:05Z","timestamp":1778355185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725026557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666636725026557"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.994","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in the Central Nervous System","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}